Experts and Doctors on antineoplastic agents in Chengdu, Sichuan, China


Locale: Chengdu, Sichuan, China
Topic: antineoplastic agents

Top Publications

  1. Fu J, Fang F, Xie L, Chen H, He F, Wu T, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012;10:CD007289 pubmed publisher
    ..As P-Chem may increase drug resistance, delay treatment of GTN and expose women unnecessarily to toxic side effects, this practice cannot currently be recommended. ..
  2. Wang Y, Luo X, Yang D, Zhang J, Zhuo H, Zhang J, et al. Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study. World J Gastroenterol. 2013;19:923-30 pubmed publisher
    ..Less than 20% of patients received HBV testing before chemotherapy. HBV reactivation would have occurred in about 50% of infected patients with solid tumors without antiviral prophylaxis. ..
  3. Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, et al. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J Control Release. 2010;145:17-25 pubmed publisher
    ..These results suggested that this FGFR-mediated drug delivery system may provide a new treatment strategy for tumors which overexpress FGFRs. ..
  4. Xie Y, Deng Y, Dai X, Liu J, Ouyang L, Wei Y, et al. Synthesis and biological evaluation of novel acenaphthene derivatives as potential antitumor agents. Molecules. 2011;16:2519-26 pubmed publisher
    ..Among them, compound 3c shows the best antitumor activity against SKRB-3 cell line, as high as the positive control adriamycin. ..
  5. Sun Y, Zou W, Bian S, Huang Y, Tan Y, Liang J, et al. Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma. Biomaterials. 2013;34:6818-28 pubmed publisher
  6. Ouyang G, Tong R, Li J, Bai L, Ouyang L, Duan X, et al. Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives. Molecules. 2016;21:516 pubmed publisher
    ..6 μM). Flow cytometry data revealed that compound 5b induced apoptosis of HCC1937 cells with increased solution concentration. The structure and activity relationships (SAR) of these compounds is summarized. ..
  7. Tan G, Tian L, Wei Y, Zhao X, Li J, Wu Y, et al. Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities. Int J Cancer. 2004;112:701-6 pubmed
    ..These observations may provide the basis for an effective alternative strategy for cancer therapy in the near future. ..
  8. Yang H, Li K, Liu Y, Liu Z, Miyoshi H. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect. J Nanosci Nanotechnol. 2009;9:282-7 pubmed
  9. Liu Z, Qiu M, Tang Q, Liu M, Lang N, Bi F. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines. Chin J Cancer. 2010;29:661-7 pubmed
    ..CD133 was overexpressed while CD44 level remained unchanged in SW620/L-OHP and LoVo/L-OHP cells. SW620/L-OHP and LoVo/L-OHP cell lines show a typical and stably resistant phenotype and may be used as research models. ..

More Information

Publications114 found, 100 shown here

  1. Gou M, Men K, Zhang J, Li Y, Song J, Luo S, et al. Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine. ACS Nano. 2010;4:5573-84 pubmed publisher
    ..The HPEI nanogels delivering pVSVMP have promising application in treating colon carcinoma. ..
  2. Peng X, Gong F, Wei M, Chen X, Chen Y, Cheng K, et al. Proteomic analysis of cell lines to identify the irinotecan resistance proteins. J Biosci. 2010;35:557-64 pubmed
    ..Identification of such proteins could allow improved understanding of the mechanisms leading to the acquisition of chemoresistance. ..
  3. Yan J, Wang Q, Zheng X, Sun H, Zhou Y, Li D, et al. Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochem Biophys Res Commun. 2012;417:842-6 pubmed publisher
    ..Data from this study thus provide strong in vivo evidence supporting that luteolin is a potential sensitizer for TRAIL in anticancer therapy. ..
  4. Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep. 2012;5:1295-8 pubmed publisher
  5. Gong C, Wang C, Wang Y, Wu Q, Zhang D, Luo F, et al. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale. 2012;4:3095-104 pubmed publisher
    ..Thus, the results suggested the micelles-hydrogel DDDS may have great potential clinical applications. ..
  6. Nie Y, Ji L, Ding H, Xie L, Li L, He B, et al. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Theranostics. 2012;2:1092-103 pubmed publisher
    ..It may give deeper understanding on the liposome formulation which is critical for liposome associated drug research and development. ..
  7. Wang G, Peng F, Cao D, Yang Z, Han X, Liu J, et al. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors. Bioorg Med Chem. 2013;21:6844-54 pubmed publisher
    ..In summary, these findings suggest that 9e is a promising new antimitotic compound for the potential treatment of cancer. ..
  8. Huang Y, Zhang Z, Liu W. [Biodistribution of N-(2-hydroxypropyl) methacrylamide copolymer-bound mitoxantrone in mice bearing Ehrlich solid tumor]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004;21:930-4 pubmed
    ..These results show the possibility of targeting anticancer drug-Mitoxantrone with secondary amino residue to the tumor tissue by HPMA copolymer as carrier. ..
  9. Zeng H, Li X, Yao J, Zhu Y, Liu J, Yang Y, et al. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib. Urol Int. 2009;83:482-5 pubmed publisher
    ..To the best of our knowledge, this is the first reported case of multifocal brain metastases in renal cell carcinoma with complete response to sunitinib. ..
  10. Xing H, Yang X, Liu T, Lin J, Chen X, Gong Y. The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line. Leuk Res. 2012;36:509-13 pubmed publisher
    ..The combination of imatinib with rapamycin can partially overcome the resistance and blockade of the ubiquitin-proteasome can be also a promising pathway to overcome imatinib resistance. ..
  11. Huang T, Huang Y, Qing X, Xia Y, Luo X, Ye T, et al. Synthesis and biological evaluation of novel N-methyl-picolinamide-4-thiol derivatives as potential antitumor agents. Molecules. 2012;17:6317-30 pubmed publisher
    ..The biological results were rationalized by the molecular docking study, which indicated the stable interactions of 6p with the Aurora-B kinase. ..
  12. He W, Wang Q, Srinivasan B, Xu J, Padilla M, Li Z, et al. A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy. Oncogene. 2014;33:3004-13 pubmed publisher
    ..These results thus establish a novel mechanism for killing cancer cells that involves autophagy-mediated necroptosis, which may be employed for overcoming chemoresistance. ..
  13. Shi W, Deng J, Tong R, Yang Y, He X, Lv J, et al. Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells. Mol Med Rep. 2016;13:3423-32 pubmed publisher
    ..The present study clarified the molecular mechanisms underlying mangiferin-induced antitumor activities, and suggested that mangiferin may be considered a potential antineoplastic drug for the future treatment of cancer. ..
  14. Cao D, Wang X, Lei L, Ma L, Wang F, Wang C, et al. Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents. Bioorg Med Chem Lett. 2016;26:1931-5 pubmed publisher
    ..Importantly, 7a significantly inhibited tumor growths in HepG2 xenograft models without causing significant loss of body weight, suggesting that 7a is a promising new anticancer agent to be developed. ..
  15. Yang K, Wang Y, Chen X, Chen H. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis. Clin Drug Investig. 2010;30:229-41 pubmed publisher
    ..Larger well designed RCTs should be carried out in the future to clarify the role of bevacizumab in the treatment of NSCLC. ..
  16. Gao X, Wang B, Wei X, Men K, Zheng F, Zhou Y, et al. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale. 2012;4:7021-30 pubmed publisher
    ..Our data suggested that QU/MPEG-PCL micelles were a novel nano-formulation of quercetin with a potential clinical application in ovarian cancer therapy. ..
  17. Yang L, Cheng P, Peng X, Shi H, He W, Cui F, et al. Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma. J Exp Clin Cancer Res. 2009;28:75 pubmed publisher
    ..Our data indicate that Ad-PEDF may provide an effective approach to inhibit mouse B16-F10 melanoma growth. ..
  18. Luo X, Xu G, Song H, Yang S, Yan S, Jia G, et al. Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation. Eur J Pharm Biopharm. 2012;82:545-53 pubmed publisher
    ..Therefore, acid-labile electrospun fibers may be promising implants for localized therapy of inoperable tumors and for prevention of post-surgical tumor recurrence. ..
  19. Wang Z, Wu X, Zeng W, Xu G, Xu H, Weng M, et al. Meta-analysis of the efficacy of sorafenib for hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14:691-4 pubmed
    ..However, there was no significant difference in the incidence of hypodynamia between the two groups. Sorafenib exerts significant curative effects in hepatocellular carcinoma. ..
  20. Li D, Zhong Y, Zhou Y, Sun H, Zheng X, Zhao C, et al. Autocrine TNF-?-mediated NF-?B activation is a determinant for evasion of CD40-induced cytotoxicity in cancer cells. Biochem Biophys Res Commun. 2013;436:467-72 pubmed publisher
    ..Our results indicate that autocrine TNF-?-mediated NF-?B activation is a determinant for cancer cells' evasion of CD40L-induced cytotoxicity and blocking NF-?B may have potential for improve the value of CD40 as an anticancer agent. ..
  21. He Z, Yu Y, Zhang Y, Yan Y, Zheng Y, He J, et al. Gene delivery with active targeting to ovarian cancer cells mediated by folate receptor alpha. J Biomed Nanotechnol. 2013;9:833-44 pubmed
    ..All the data indicated that F-PEG-CLPs would be a promising gene vector targeting for ovarian cancer therapy. ..
  22. Lu B, Xiong S, Yang H, Yin X, Chao R. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci. 2006;28:86-95 pubmed
    ..83 +/- 77.71 mm3. This study opens a new perspective of active delivery of antitumor drug against breast cancer and its lymph node metastases with inspiring therapeutic effect and little side effects. ..
  23. Xia L, Zhang M, Ji L, Li X, Wu X. Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors. Surg Today. 2010;40:936-42 pubmed publisher
    ..04). These findings suggest that surgical intervention in combination with imatinib treatment is more effective than imatinib alone against GIST liver metastases, with minimal complications and side effects. ..
  24. Han X, Luo J, Wu F, Hou X, Yan G, Zhou M, et al. Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents. Eur J Med Chem. 2016;114:232-43 pubmed publisher
    ..Moreover, it inhibited tumor growth in HCT116 subcutaneously implanted xenografted mice. Taken together, compound 35 may be a promising candidate for anti-cancer agent as well as metastatic one. ..
  25. Liu R, He B, Li D, Lai Y, Chang J, Tang J, et al. Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles. Int J Nanomedicine. 2012;7:4433-46 pubmed publisher
    ..0. The inhibition effect of mPEG(45)-PH(15)-PLLA(82) nanoparticles on the growth of HepG2 cells was greater than that of mPEG(45)-PH(30)-PLLA(82) nanoparticles when the concentration of encapsulated doxorubicin was less than 15 ?g/mL. ..
  26. Yuan Y, Zhao Y, Xin S, Wu N, Wen J, Li S, et al. A novel PEGylated liposome-encapsulated SANT75 suppresses tumor growth through inhibiting hedgehog signaling pathway. PLoS ONE. 2013;8:e60266 pubmed publisher
    ..Our findings suggest that liposomal formulated SANT75 has improved solubility and bioavailability and should be further developed as a drug candidate for treating tumors with abnormally high Hh activity. ..
  27. Zhang N, Liu Y, Wang Y, Zhao M, Tu L, Luo F. Decitabine reverses TGF-?1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. Drug Des Devel Ther. 2017;11:969-983 pubmed publisher
    ..Our findings suggest that epigenetic regulation of the miR-200/ZEB axis is responsible for EMT induction by TGF-?1 in PC9 cells. Decitabine inhibits EMT in NSCLC cell PC9 through its epigenetic-based therapeutic activity. ..
  28. Shu L, Huang R, Wu S, Chen Z, Sun K, Jiang Y, et al. PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System. Curr Stem Cell Res Ther. 2016;11:274-81 pubmed
    ..This review highlights key advances in understanding the effects of PPARγ ligands in the treatment of tumors in the digestive system. ..
  29. Zhang J, Jiang X, Jiang Y, Guo M, Zhang S, Li J, et al. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs. Eur J Med Chem. 2016;108:495-504 pubmed publisher
    ..Newly collection derivatives have been mainly describing in their biological profiles and chemical structures. ..
  30. Gao J, Ming J, He B, Fan Y, Gu Z, Zhang X. Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery. Eur J Pharm Sci. 2008;34:85-93 pubmed publisher
    ..The novel PECA copolymer micelles could be effective carriers to improve the solubility, stability, and release performance of 9-NC. ..
  31. Sun J, Xu X, Ni C, Zhang H, Li X, Zhang C, et al. Crocin inhibits proliferation and nucleic acid synthesis and induces apoptosis in the human tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Cancer Prev. 2011;12:2679-83 pubmed
    ..4 mM crocin compared with the negative control (P<0.01). Our observations support the feasibility of applying crocin as a chemoprophylactic agent and treatment for OSCCs. ..
  32. Guo X, Shi C, Wang J, Di S, Zhou S. pH-triggered intracellular release from actively targeting polymer micelles. Biomaterials. 2013;34:4544-54 pubmed publisher
    ..In vivo antitumor activity demonstrated that FA-hyd micelles had the highest safety to body and the best therapeutic efficacy to tumors. Therefore, this drug delivery system is deemed as a potential nanocarrier for cancer therapy. ..
  33. Liu G, Luo Q, Gao H, Chen Y, Wei X, Dai H, et al. Cell membrane-inspired polymeric micelles as carriers for drug delivery. Biomater Sci. 2015;3:490-9 pubmed publisher
    ..This result suggests that these biomimetic polymeric micelles may be promising drug delivery systems in cancer therapy. ..
  34. Yao B, He Q, Tian L, Xiao F, Jiang Y, Zhang R, et al. Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models. Hum Gene Ther. 2005;16:1075-86 pubmed
    ..A combination of these agents could be used in future studies and translated into the clinical setting. ..
  35. Liu B, Bian H, Bao J. Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett. 2010;287:1-12 pubmed publisher
    ..In conclusion, these inspiring findings would open a new perspective for plant lectins as potential antineoplastic drugs from bench to clinic. ..
  36. Ma Y, Yang Y, Zhang S, Chen X, Zhang N, Wang W, et al. Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP. J Exp Clin Cancer Res. 2010;29:56 pubmed publisher
    ..Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer. ..
  37. Cai L, Wang X, Wang W, Qiu N, Wen J, Duan X, et al. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo. Int J Nanomedicine. 2012;7:4499-510 pubmed publisher
    ..The truncated fibroblast growth factor fragment-conjugated PEGylated liposome has promising potential as a long-circulating and tumor-targeting carrier system. ..
  38. Liu Y, Song N, Ren K, Meng S, Xie Y, Long Q, et al. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. PLoS ONE. 2013;8:e78417 pubmed publisher
  39. Su T, Yang H, Fan Q, Jia D, Tao Z, Wan L, et al. Enhancing the circulating half-life and the antitumor effects of a tumor-selective cytotoxic peptide by exploiting endogenous serum albumin as a drug carrier. Int J Pharm. 2016;499:195-204 pubmed publisher
    ..These results suggest that half-life extension via ABD fusion represents a useful strategy for optimizing bombesin-directed pharmaceuticals for cancer-targeted therapy. ..
  40. Cao M, Deng H, Zhao J, Fan L, Jiang Y, Wen Y, et al. Antitumour activity of cationic-liposome-conjugated adenovirus containing the CCL19 [chemokine (C-C motif) ligand 19] gene. Biotechnol Appl Biochem. 2007;48:109-16 pubmed
    ..The results demonstrated that PEG-PE-cationic-liposome-conjugated adenovirus could prolong the expression of the therapeutic gene in vivo and may enhance the antitumour efficacy. ..
  41. Fu L, Mao Z, Wang J, Zhang J, Zheng T, Wang S. [Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao. 2009;7:509-13 pubmed publisher
    ..05). Western medicine combined with SXC has long-lasting effects in lowering heart rate and blood pressure, especially for SBP and SBP load. SXC plus Western medicine also has an inhibition effect on morning surge in blood pressure. ..
  42. Liu J, Peng L, Niu T, Wu Y, Li J, Wang F, et al. PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization. Oncotarget. 2016;7:4841-59 pubmed publisher
    ..Once this process was beyond the limit of intrinsic antagonism, it induced programmed cell death cooperatively via caspase-independent and caspase-dependent pathways. ..
  43. Chen W, Zhang Y, Li Y, Zhang J, Zhang T, Fu B, et al. Constitutive expression of Wnt/β‑catenin target genes promotes proliferation and invasion of liver cancer stem cells. Mol Med Rep. 2016;13:3466-74 pubmed publisher
    ..Therefore, these data suggest that Wnt/β‑catenin signaling is a potential therapeutic target to reduce CSC‑mediated tumorigenicity and invasion in liver cancer. ..
  44. Tong Q, He Y, Zhao Q, Qing Y, Huang W, Wu X. Cytotoxicity and apoptosis-inducing effect of steroidal saponins from Dioscorea zingiberensis Wright against cancer cells. Steroids. 2012;77:1219-27 pubmed publisher
  45. Ding M, Song N, He X, Li J, Zhou L, Tan H, et al. Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment. ACS Nano. 2013;7:1918-28 pubmed publisher
  46. Li K, Mo C, Gong D, Chen Y, Huang Z, Li Y, et al. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin. Cancer Lett. 2017;400:194-202 pubmed publisher
  47. Hu J, Wu T, Li H, Zuo Z, Zhao Y, Yang L. The synthesis, structure-toxicity relationship of cisplatin derivatives for the mechanism research of cisplatin-induced nephrotoxicity. Bioorg Med Chem Lett. 2017;27:3591-3594 pubmed publisher
  48. He L, Li D, Zhang C, Bai P, Chen L. Discovery of (R)-5-(benzo[d][1,3]dioxol-5-yl)-7-((1-(vinylsulfonyl)pyrrolidin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (B6) as a potent Bmx inhibitor for the treatment of NSCLC. Bioorg Med Chem Lett. 2017;27:4171-4175 pubmed publisher
    ..7±0.1nM) over other kinases. So, as a potent Bmx inhibitor, B6 has the potential to be an efficacious treatment for NSCLC with acquired drug resistance. ..
  49. Li G, Li B, Yang T, Yan J, Liu G, Zhang G. Chaetocochins A-C, epipolythiodioxopiperazines from Chaetomium cochliodes. J Nat Prod. 2006;69:1374-6 pubmed
    ..Their structures were elucidated on the basis of spectroscopic analysis. Compounds 1, 3, and 4 exhibited significant cytotoxicity in vitro against cancer cell lines Bre-04, Lu-04, and N-04...
  50. Guan Y, He Q, Wang M, Li P. Nuclear factor kappa B and hepatitis viruses. Expert Opin Ther Targets. 2008;12:265-80 pubmed publisher
    ..Nuclear factor kappa B (NF-kappaB) is critical for immune and inflammatory responses. During its lifetime the cell demands specific and highly regulated control of NF-kappaB activity...
  51. Peng H, Lv H, Wang Y, Liu Y, Li C, Meng L, et al. Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities. Peptides. 2009;30:1805-15 pubmed publisher
  52. Luo S, Chen P, Luo Z, Zhang P, Sun P, Shi W, et al. Combination of vesicular stomatitis virus matrix protein gene therapy with low-dose cisplatin improves therapeutic efficacy against murine melonoma. Cancer Sci. 2010;101:1219-25 pubmed publisher
    ..Our findings may prove useful in further explorations of the application of these combinational approaches to the treatment of malignant melanoma...
  53. Wang S, Yu Q, Bao J, Liu B. Polygonatum cyrtonema lectin, a potential antineoplastic drug targeting programmed cell death pathways. Biochem Biophys Res Commun. 2011;406:497-500 pubmed publisher
    ..In conclusion, these findings may provide a new perspective of Polygonatum cyrtonema lectin (PCL) as a potential anti-tumor drug targeting PCD pathways for future cancer therapeutics...
  54. Li C, Wang Y, Wang H, Shi Z, An N, Liu Y, et al. Molecular mechanisms of Lycoris aurea agglutinin-induced apoptosis and G2 /M cell cycle arrest in human lung adenocarcinoma A549 cells, both in vitro and in vivo. Cell Prolif. 2013;46:272-82 pubmed publisher
    ..Lycoris is aurea agglutinin (LAA) has attracted rising attention due to its remarkable bioactivities. Here, we aimed at investigating its anti-tumor activities...
  55. Yao D, Zhou Y, Zhu L, Ouyang L, Zhang J, Jiang Y, et al. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer. Eur J Med Chem. 2017;140:155-171 pubmed publisher
    ..In vitro experiments revealed that Y29 attenuated metastasis by PDGFR-? inhibition-induced autophagy and could enhance autophagy-related cell death through AKT-MAPK feedback loop in MDA-MB-231 cells. ..
  56. Xiao X, Zou J, Fang Y, Meng Y, Xiao C, Fu J, et al. Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells. BMC Complement Altern Med. 2018;18:91 pubmed publisher
    ..Further studies will be needed to validate the therapeutic potential of fisetin and fisetin micelles in ovarian cancer treatment. ..
  57. Xiong W, Huang N, Feng Y, Wu Q, Wang B. Creation and anti-cancer potency in HeLa cells of a novel chimeric toxin, HMGNCIDIN, composed of HMGN2 a-helical domain and PE38 KDEL domain III. Chin Med J (Engl). 2008;121:82-5 pubmed
  58. Yu X, Luo Y, Zhou Y, Zhang Q, Wang J, Wei N, et al. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model. Int J Oncol. 2008;33:555-63 pubmed
  59. Xie C, Zheng L, Li Z, Zhao X. Spontaneous uterine perforation of choriocarcinoma with negative beta-human chorionic gonadotropin after chemotherapy. Med Princ Pract. 2011;20:570-3 pubmed publisher
    ..To report an extremely rare case of spontaneous uterine perforation of choriocarcinoma with negative beta-human chorionic gonadotropin (?-hCG) post-chemotherapy...
  60. Yi Y, Chen D, Ao J, Sun S, Wu M, Li X, et al. Metformin Promotes AMP-activated Protein Kinase-independent Suppression of ?Np63? Protein Expression and Inhibits Cancer Cell Viability. J Biol Chem. 2017;292:5253-5261 pubmed publisher
  61. Shao M, He L, Zheng L, Huang L, Zhou Y, Wang T, et al. Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors. Bioorg Med Chem Lett. 2017;27:4051-4055 pubmed publisher
    ..Those results indicated that 16ae is a potent dual BRD4/HDAC inhibitor and deserves further investigation. ..
  62. Wen F, Zhou Y, Wang W, Hu Q, Liu Y, Zhang P, et al. Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis. Ann Oncol. 2013;24:171-8 pubmed publisher
    ..61-1.10; P=0.18). Ca/Mg infusions tend to decrease the incidence of oxaliplatin-induced acute and cumulative neurotoxicity and thus enhance patients' tolerance to oxaliplatin, without significantly altering the efficacy of chemotherapy. ..
  63. Zhao L, Li X, Zhang L, Ye T, Zhu Y, Wei Y, et al. Novel small molecules as apoptosis inducers: synthesis, preliminary structure-activity relationships, and in vitro biological evaluation. Bioorg Med Chem Lett. 2013;23:2293-7 pubmed publisher
    ..The SAR analysis indicated that the substituents R(2) played a crucial role in the antiproliferation activity. ..
  64. Hao N, Sun C, Wu Z, Xu L, Gao W, Cao J, et al. Fabrication of Polymeric Micelles with Aggregation-Induced Emission and Forster Resonance Energy Transfer for Anticancer Drug Delivery. Bioconjug Chem. 2017;28:1944-1954 pubmed publisher
    ..In summary, this micelle provided an effective way to fabricate novel nanoplatform for intracellular imaging, drug-delivery tracing, and chemotherapy...
  65. Wang X, Duan X, Yang G, Zhang X, Deng L, Zheng H, et al. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS ONE. 2011;6:e18490 pubmed publisher
    ..Here, we hypothesized that honokiol could cross the BBB and BCSFB for the treatment of gliosarcoma...
  66. Xu Y, Zheng R, Zhou Y, Peng F, Lin H, Bu Q, et al. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo. Cancer Lett. 2011;313:44-53 pubmed publisher
    ..Its potential to be a candidate of anticancer agent is worth being further investigated. ..
  67. Long Q, Xiel Y, Huang Y, Wu Q, Zhang H, Xiong S, et al. Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers. J Biomed Nanotechnol. 2013;9:965-75 pubmed
    ..Therefore, our results suggest that Lipo-Que is an effective agent to inhibit tumor growth in both cisplatin-sensitive and cisplatin-resistant human ovarian cancers. ..
  68. Gao J, Yin M, Zhu Y, Gu L, Zhang Y, Li Q, et al. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma. BMC Cancer. 2013;13:471 pubmed publisher
    ..The AKT/mTOR signaling pathway is highly activated in ALK?+?ALCL patients and targeting the AKT/mTOR signaling pathway might confer a great therapeutic potential in ALCL. ..
  69. Shi W, Tang Q, Chen X, Cheng P, Jiang P, Jing X, et al. Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer. J Mol Med (Berl). 2009;87:493-506 pubmed publisher
  70. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs. 2009;20:757-69 pubmed publisher
  71. Tang X, Xie P, Ding Y, Chu L, Hou J, Yang J, et al. Synthesis, characterization, and in vitro and in vivo evaluation of a novel pectin-adriamycin conjugate. Bioorg Med Chem. 2010;18:1599-609 pubmed publisher
    ..Compared with ADM and the mixture of ADM and pectin, PAC suppressed tumor growth significantly and prolonged the mean survival time of the B16-inoculated mice. PAC has great potential for development as a tumor targeting polymer-drug. ..
  72. Wang G, Wu W, Peng F, Cao D, Yang Z, Ma L, et al. Design, synthesis, and structure-activity relationship studies of novel millepachine derivatives as potent antiproliferative agents. Eur J Med Chem. 2012;54:793-803 pubmed publisher
    ..Further studies confirmed that 15 significantly suppressed the growth of tumor volume and exerted more potent anticancer potency than millepachine and anticancer drug cisplatin in A549 lung xenograft tumor model. ..
  73. He H, Wang X, Zheng X, Sun H, Shi X, Zhong Y, et al. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity. Cancer Lett. 2010;295:38-43 pubmed publisher
    ..These data suggest that NF-kappaB and Akt cooperatively attenuate therapeutic-induced cytotoxicity and concurrently blocking these pathways is an effective strategy for improving the anticancer efficacy of therapeutics. ..
  74. Fu L, Zhou C, Yao S, Yu J, Liu B, Bao J. Plant lectins: targeting programmed cell death pathways as antitumor agents. Int J Biochem Cell Biol. 2011;43:1442-9 pubmed publisher
    ..And, this research may, in turn, ultimately help cancer biologists and clinicians to exploit lectins as potential novel antitumor drugs in the future...
  75. Sun H, Zhong Y, Zheng X, Wang Q, Yang L, Shi F, et al. Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells. Cancer Sci. 2012;103:197-202 pubmed publisher
  76. Chen Q, Li D, Ren J, Li C, Xiao Z. MUC1 activates JNK1 and inhibits apoptosis under genotoxic stress. Biochem Biophys Res Commun. 2013;440:179-83 pubmed publisher
    ..Together, our data indicate that MUC1 can inhibit apoptosis via activating JNK1 pathway in response to genotoxic anticancer agents. ..
  77. Lu W, Cheng F, Yan W, Li X, Yao X, Song W, et al. Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. Oncogene. 2017;36:4719-4731 pubmed publisher
    ..Collectively, this study demonstrates that pharmacologic inhibition of CypA offers a potential therapeutic strategy via specific activation of p53-72R in NSCLC. ..
  78. Yu D, Wang C, Shi H, Li Z, Pan L, Yuan Q, et al. Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant. J Exp Clin Cancer Res. 2010;29:46 pubmed publisher
    ..The aim of this study was to determine whether a dominant-negative mouse survivin mutant could enhance the anti-tumor activity of CDDP...
  79. Mou Z, Deng N, Zhang F, Zhang J, Cen J, Zhang X. "Half-sandwich" Schiff-base Ir(III) complexes as anticancer agents. Eur J Med Chem. 2017;138:72-82 pubmed publisher
  80. Chen L, Feng P, Li S, Long D, Cheng J, Lu Y, et al. Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide. Neurochem Res. 2009;34:984-90 pubmed publisher
    ..These findings suggest that the HIF-1alpha plays a role in mediating chemotherapeutic drug resistance in glioma cells. HIF-1alpha silencing may prove to be an effective therapeutic means of treating gliomas. ..
  81. Liu S, Wu M, Zhang Z. Involvement of DNA polymerase beta in repairing oxidative damages induced by antitumor drug adriamycin. Toxicol Appl Pharmacol. 2010;246:163-70 pubmed publisher
    ..These findings suggested that pol ? is vital for repairing oxidative damage induced by ADM. ..
  82. Lin C, Zhao X, Li L, Liu H, Cao K, Wan Y, et al. NOXA-induced alterations in the Bax/Smac axis enhance sensitivity of ovarian cancer cells to cisplatin. PLoS ONE. 2012;7:e36722 pubmed publisher
    ..Taken together, our findings show that NOXA is potentially useful as a chemosensitizer in ovarian cancer therapy. ..
  83. Cao D, Han X, Wang G, Yang Z, Peng F, Ma L, et al. Synthesis and biological evaluation of novel pyranochalcone derivatives as a new class of microtubule stabilizing agents. Eur J Med Chem. 2013;62:579-89 pubmed publisher
    ..Further studies confirmed that 10i significantly suppressed the growth of tumor volume in HepG2 xenograft tumor model. Our study demonstrated that 10i could have beneficial antitumor activity as a novel microtubule stabilizing agent. ..
  84. Sun L, Liao G, Gao J, Chen T, Pan L, Yuan L. [Expression of mitochondrial ferritin in K562 leukemic cell during ATRA-induced cell differentiation]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41:77-80, 90 pubmed
    ..The coordinated expression regulation of these key iron metabolism-related molecules during cell differentiation may in turn inhibit TfR1-mediated iron uptake via endocytosis and thus adversely affect cell proliferation potential. ..
  85. Yang L, Wang H, Jia X, Wang X, Luo J, Zhang X. [Expression of miR-130a in cisplatin resistant cell lines of ovarian cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43:60-4 pubmed
    ..Inhibiting miR-130a expression may help reverse the cisplatin resistance of ovarian cancer. miR-130a is expected to be a new potential target of genetic therapy for cisplatin resistant ovarian cancer. ..
  86. Leng Y, Hou J, Jin J, Zhang M, Ke X, Jiang B, et al. Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study. Cancer Chemother Pharmacol. 2017;79:1141-1149 pubmed publisher
    ..7% of the patients. No treatment-related deaths were reported. CPT plus TD could serve as a new therapeutic strategy for patients with RRMM. A randomized, double-blind, placebo-controlled confirmatory study is currently under way. ..
  87. Wang W, Wang K, Gao Q, Chen L. Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction. World J Surg Oncol. 2012;10:14 pubmed publisher
    ..The aim of this study was to investigate the existence of EGFR mutations in carcinoma of esophagogastric junction, and also to explore the possibility of treating carcinoma of esophagogastric junction using gefitinib...
  88. Liu G, Wang C, Ding Z. Overexpression of the truncated form of Livin reveals a complex interaction with caspase-3. Int J Oncol. 2013;42:2037-45 pubmed publisher
    ..This second cleavage was possibly related to activated caspase-3. The resulted C-terminal fragment (livC) was an anti-apoptotic factor. Our study may help to deepen our understanding of the role of Livin in the regulation of cell death. ..
  89. Zhao L, Yu C, Zhou S, Lau W, Lau B, Luo Z, et al. Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling. Oncotarget. 2016;7:1408-20 pubmed publisher
    ..These results suggest that PDLIM2 might be involved in ovarian cancer pathogenesis, which could serve as a promising therapeutic target for ovarian cancer patients. ..
  90. Wang J, Yin Y, Hua H, Li M, Luo T, Xu L, et al. Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med. 2009;13:3888-97 pubmed publisher
    ..Combination of compounds capable of suppressing GRP78 might be a novel approach for improving the effectiveness of microtubules-targeted chemotherapy. ..
  91. Wu Q, Gong C, Luo S, Zhang D, Zhang S, Shi H, et al. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model. BMC Cancer. 2012;12:129 pubmed publisher
    ..Thus, our results suggest that rAAV2-hPEDF may be a potential candidate as an antiangiogenic therapy agent. ..
  92. Zhang X, Wang L, Li F, Yu K, Wang M. Cytotoxic phorbol esters of Croton tiglium. J Nat Prod. 2013;76:858-64 pubmed publisher
    ..The cytotoxic activities of the phorbol diesters were evaluated against the SNU387 hepatic tumor cell line, and compound 3 exhibited the most potent activity (IC50 1.2 ?M)...